Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Pelucchi, Claudio ^a   Esposito, Susanna ^b   Galeone, Carlotta ^a   Semino, Margherita ^b   Sabatini, Caterina ^b   Picciolli, Irene ^b   Consolo, Silvia ^b   Milani, Gregorio ^b   Principi, Nicola ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; ITALY; MALE; PAPILLOMAVIRUS INFECTION; PARENT; QUESTIONNAIRE; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; QUESTIONNAIRES; VACCINATION;

EID: 77953946501     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-378     Document Type: Article

References (51)

1. Human papillomaviruses. IARC, Lyon International Agency for Research on Cancer 2007
2. Age-specific prevalence of infection with human papillomavirus in females: A global review. JS Smith A Melendy RK Rana JM Pimenta, J Adolesc Health 2008 43 4 Suppl 5 S25 18809145
3. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. MR Gillison, J Adolesc Health 2008 43 4 Suppl 52 S60 10.1016/j.jadohealth.2008.07.002 18809146
4. Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. M Sideri P Cristoforoni C Casadio S Boveri S Igidbashian M Schmitt T Gheit M Tommasino, Vaccine 2009 27 Suppl 1 30 A33 10.1016/j.vaccine.2008.12.028 19480958
5. HPV infection in Europe. H De Vuyst G Clifford N Li S Franceschi, Eur J Cancer 2009 45 2632 S2639 10.1016/j.ejca.2009.07.019 19709878
6. Epidemiology of mucosal human papillomavirus infection and associated diseases. H Trottier AN Burchell, Public Health Genomics 2009 12 5-6 291 307 10.1159/000214920 19684442
7. Human papillomavirus (HPV) vaccine: A position statement of the Society for Adolescent Medicine. LS Friedman J Kahn AB Middleman SL Rosenthal GD Zimet Society for Adolescent Medicine, J Adolesc Health 2006 39 620 10.1016/j.jadohealth.2006.07.013 16982407
8. Human papillomavirus vaccination. Consensus Conference in pediatric age. G Bartolozzi G Bona M Ciofi M De Martino P Di Pietro M Duse S Esposito R Gasparini L Mariani G Marostica F Paravati A Plebani N Principi GV Zuccotti PA Tovo, Minerva Pediatr 2007 59 165 182 17519861
9. An update on human papillomavirus infection and Papanicolau smears in adolescents. JA Kahn, Curr Opin Pediatr 2001 13 303 309 10.1097/00008480- 200108000-00003 11717553
10. Prevalence of HPV infection among females in the United States. EF Dunne ER Unger M Sternberg G McQuillan DC Swan SS Patel LE Markowitz, JAMA 2007 297 813 819 10.1001/jama.297.8.813 17327523
11. Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. TF Schwarz M Spaczynski A Schneider J Wysocki A Galaj P Perona S Poncelet T Zahaf K Hardt D Descamps G Dubin HPV Study Group for Adult Women, Vaccine 2009 27 581 587 10.1016/j.vaccine.2008.10.088 19022320
12. Development of therapeutic HPV vaccines. CL Trimble IH Frazer, Lancet Oncol 2009 10 975 980 10.1016/S1470-2045(09)70227-X 19796749
13. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. N Munoz R Manalastas Jr P Pitisuttithum D Tresukosol J Monsonego K Ault C Clavel J Luna E Myers S Hood O Bautista J Bryan FJ Taddeo MT Esser S Vuocolo RM Haupt E Barr A Saah, Lancet 2009 373 1949 1957 10.1016/S0140-6736(09)60691-7 19493565
14. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. X Castellsague A Schneider AM Kaufmann FX Bosch, Gynecol Oncol 2009 115 15 S23 10.1016/j.ygyno.2009.09.021 19819540
15. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. S Esposito S Bosis C Pelucchi E Begliatti A Rognoni M Bellasio F Tel S Consolo N Principi, Vaccine 2007 25 6437 6646 10.1016/j.vaccine.2007.06.053 17673339
16. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. L Brabin SA Roberts F Farzaneh HC Kitchener, Vaccine 2006 24 3087 3094 10.1016/j.vaccine.2006.01.048 16500736
17. Adolescent girls' attitudes on human papillomavirus vaccination. SS Chan BH Yan Ng WK Lo TH Cheung TK Hung Chung, J Pediatr Adolesc Gynecol 2009 22 85 90 10.1016/j.jpag.2007.12.007 19345913
18. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. G Di Giuseppe R Abbate G Liguori L Albano IF Angelillo, Br J Cancer 2008 99 225 229 10.1038/sj.bjc.6604454 18628763
19. Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program. AE Tozzi L Rav D Stat E Pandolfi MG Marino AG Ugazio, Vaccine 2009 27 2625 2629 10.1016/j.vaccine.2009.02.050 19428869
20. Knowledge of cervix cancer human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. GG Donders M Gabrovska G Bellen,, et al. Arch Gynecol Obstet 2008 277 291 298 10.1007/s00404-007-0487-1 17965870
21. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. JL Winkler S Wittet RM Bartolini J Van Keirsbilck T Van Den Bosch I Riphagen M Verjans, Vaccine 2008 26 Suppl 11 73 L79 10.1016/j.vaccine.2008.05.027 18945404
22. Comparison of quality of internet pages on human papillomavirus immunization in Italian and in English. AE Tozzi PS Buonuoma ML Ciofi degli Atti E Carloni M Meloni F Gamba, J Adolesc Health 2010 46 83 89 10.1016/j. jadohealth.2009.05.006 20123262
23. Effectiveness of a training intervention on immunization to increase knowledge of primary healthcare workers and vaccination coverage rates. E Uskun SB Uskun M Uysalgenc M Yagiz, Public Health 2008 122 949 958 10.1016/j.puhe.2007.10.005 18313703
24. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. C Vandermeulen M Roelants H Theeten AM Depoorter P Van Damme K Hoppenbrouwers, Pediatrics 2008 121 428 e434 10.1542/peds.2007-1415 18310163
25. How can immunization coverage in urban counties be improved? A pilot study of a Kansas county. AM Paschal J Maryman J Oler-Manske, Am J Infect Control 2009 37 423 425 10.1016/j.ajic.2008.07.005 19482221
26. Ensuring the willingness to vaccinate and be vaccinated. JP Baeyens, Expert Rev Vaccines 2010 9 3 Suppl 11 14 10.1586/erv.10.28 20192712
27. Capitolo 7. Istruzione. ISTAT, Annuario statistico Italiano Rome: Istituto Nazionale di Statistica, ISTAT 2008 171 198
28. Parental attitudes to pre-pubertal HPV vaccination. LA Marlow J Waller J Wardle, Vaccine 2007 25 1945 1952 10.1016/j.vaccine.2007.01.059 17284337
29. Disparities in how parents are learning about the human papillomavirus vaccine. J Hughes JR Cates N Liddon JS Smith SL Gottlieb NT Brewer, Cancer Epidemiol Biomarkers Prev 2009 18 363 372 10.1158/1055-9965.EPI-08-0418 19190161
30. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. G Ogilvie M Anderson F Marra S McNeil K Pielak M Dawar M McIvor T Ehlen S Dobson D Money DM Patrick M Naus, PLoS Med 2010 7 1000270 10.1371/journal.pmed.1000270 20454567
31. Knowledge about infection with human papillomavirus: a systematic review. SJ Klug M Hukelmann M Blettner, Prev Med 2008 46 87 98 10.1016/j.ypmed.2007.09. 003 17942147
32. Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. WJ Christian A Christian C Hopenhayn, J Adolesc Health 2009 44 437 445 10.1016/j.jadohealth.2008.09.001 19380090
33. An experimental investigation of the emotional and motivational impact of HPV information in adolescents. GP Lloyd LA Marlow J Walter A Miles J Wardle, J Adolesc Health 2009 45 532 534 10.1016/j.jadohealth.2009.06.003 19837362
34. Acceptability of human papillomavirus vaccine for males: a review of the literature. N Liddon J Hood BA Wynn LE Markowitz, J Adolesc Health 2010 46 113 123 10.1016/j.jadohealth.2009.11.199 20113917
35. Knowledge of human papillomavirus and attitudes to vaccination among Swedish high school students. AT Hoglund T Tyden AK Hannerfors M Larsson, Int J STD AIDS 2009 20 102 107 10.1258/ijsa.2008.008200 19182055
36. University students' knowledge and awareness of HPV. E Yacobi C Tennant J Ferrante N Pal R Roetzheim, Prev Med 1999 28 535 541 10.1006/pmed.1999.0486 10404550
37. College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. EC Lambert, J Am Board Fam Pract 2001 14 178 183 11355049
38. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. R Caskey ST Lindau GC Alexander, J Adolesc Health 2009 45 453 462 10.1016/j.jadohealth.2009.04.021 19837351
39. Impact of HPV infection in adolescent populations. AB Moscicki, J Adolesc Health 2005 37 6 Suppl 3 S9 10.1016/j.jadohealth.2005.09.011 16310138
40. CancerScope: HPV vaccine for boys and men? It could help reduce incidence of cervical and head and neck cancers. C Printz, Cancer 2009 115 5129 5130 10.1002/cncr.24725 19890862
41. Assessing knowledge of human papillomavirus and collecting data on sexual behavior: computer assisted telephone versus face to face interviews. A Smith A Lyons M Pitts S Croy R Ryall S Garland ML Wong EH Tay, BMC Public Health 2009 23 429 10.1186/1471-2458-9-429
42. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. SL Rosenthal TW Weiss GD Zimet L Ma MB Good MD Vichnin, Vaccine 2010 Epub Jan 5 20056186
43. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. GL Mortensen, BMC Public Health 2010 10 68 10.1186/1471-2458-10-68 20152055
44. Mother-daughter communication and human papillomavirus vaccine uptake by college students. ME Roberts M Gerrard R Reimer FX Gibbons, Pediatrics 2010 125 982 989 10.1542/peds.2009-2888 20385645
45. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. JD Allen GD Coronado RS Williams B Glenn C Escoffery M Fernandez RA Tuff KM Wilson PD Mullen, Vaccine 2010 Epub Apr 20 20412875
46. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. NT Brewer KI Fazekas, Prev Med 2007 45 107 114 10.1016/j.ypmed.2007.05. 013 17628649
47. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. MA Gerend ZF Magloire, J Adolesc Health 2008 42 237 242 10.1016/j.jadohealth.2007.08.022 18295131
48. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. SL Rosenthal R Rupp GD Zimet HM Meza ML Loza MB Short PA Succop, J Adolesc Health 2008 43 239 245 10.1016/j.jadohealth.2008.06. 009 18710678
49. Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer. SL Gottlieb NT Brewer JS Smith KM Keating LE Markowitz, J Adolesc Health 2009 45 438 444 10.1016/j.jadohealth. 2009.05.013 19837349
50. Rapporto sull'habitat urbano del Comune di Milano. AMMA, Milan Agenzia Milanese Mobilit Ambiente 2006
51. Post-stratification against bias in sampling. P Jagers, Int Stat Rev 1986 54 159 167 10.2307/1403141